{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:14:28Z","timestamp":1788516868749,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmirs.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Imaging and Radiation Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jmir.2026.102569","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:03:25Z","timestamp":1788512605000},"page":"102569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing the therapeutic ratio of PSMA-PET-guided para-aortic radiotherapy for prostate cancer: A systematic review and structured quantitative synthesis"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6539-5432","authenticated-orcid":false,"given":"Noureddine","family":"Samai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymen","family":"Berremdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jmir.2026.102569_bib0001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.euo.2022.10.002","article-title":"Role of local and\/or metastasis-directed therapy in patients with hormone-sensitive M1a prostate cancer-a systematic review","volume":"6","author":"de Barros","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.jmir.2026.102569_bib0002","doi-asserted-by":"crossref","first-page":"228","DOI":"10.21037\/tau-24-489","article-title":"Clinical characteristics and prognostic factors of low metastatic burden prostate cancer with non-regional lymph node metastases: role of cytoreductive radiotherapy?","volume":"14","author":"Mai","year":"2025","journal-title":"Transl Androl Urol"},{"issue":"12","key":"10.1016\/j.jmir.2026.102569_bib0003","doi-asserted-by":"crossref","DOI":"10.2196\/11256","article-title":"Benefits of elective para-aortic radiotherapy for pN1 prostate cancer using arc therapy (intensity-modulated or volumetric modulated arc therapy): protocol for a nonrandomized phase II trial","volume":"7","author":"Draulans","year":"2018","journal-title":"JMIR Res Protoc"},{"issue":"13","key":"10.1016\/j.jmir.2026.102569_bib0004","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.3390\/cancers18132094","article-title":"PSMA PET in lymph node staging of prostate cancer: from diagnostic accuracy to clinical decision-making","volume":"18","author":"Esperto","year":"2026","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jmir.2026.102569_bib0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00066-024-02304-9","article-title":"Early and repetitive novel-tracer PET-guided stereotactic body radiotherapy for nodal oligorecurrent prostate cancer after definitive first-line therapy","volume":"201","author":"Gr\u00fcn","year":"2025","journal-title":"Strahlenther Onkol"},{"issue":"10","key":"10.1016\/j.jmir.2026.102569_bib0006","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1080\/0284186X.2020.1775291","article-title":"Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review","volume":"59","author":"Achard","year":"2020","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.jmir.2026.102569_bib0007","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.eururo.2019.07.009","article-title":"Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer: a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy","volume":"76","author":"De Bleser","year":"2019","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.jmir.2026.102569_bib0008","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s11547-023-01701-x","article-title":"Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysis","volume":"128","author":"Francolini","year":"2023","journal-title":"Radiol Med"},{"issue":"6","key":"10.1016\/j.jmir.2026.102569_bib0009","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1470-2045(25)00197-4","article-title":"Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial","volume":"26","author":"Ost","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmir.2026.102569_bib0010","doi-asserted-by":"crossref","DOI":"10.2340\/1651-226X.2024.40681","article-title":"Stereotactic body radiation therapy on abdominal-pelvic lymph node oligometastases: a systematic review on toxicity","volume":"63","author":"van Werkhoven","year":"2024","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jmir.2026.102569_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2026.01.001","article-title":"Health-related quality of life outcomes of salvage metastasis-directed treatment versus elective nodal treatment for oligorecurrent nodal prostate cancer: a secondary analysis of the phase 2, open-label PEACE V-STORM randomized trial","author":"Zilli","year":"2026","journal-title":"Eur Urol Oncol"},{"issue":"10","key":"10.1016\/j.jmir.2026.102569_bib0012","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/0284186X.2021.1955970","article-title":"Progression-free survival in patients with 68Ga-PSMA-PET-directed SBRT for lymph node oligometastases","volume":"60","author":"Werensteijn-Honingh","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jmir.2026.102569_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.983984","article-title":"Stomach and duodenum dose-volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy","volume":"12","author":"Broggi","year":"2023","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.jmir.2026.102569_bib0014","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.3390\/jcm13113291","article-title":"SBRT in lymph-nodal oligometastases from prostate cancer: different outcomes between pelvic and para-aortic disease","volume":"13","author":"Pastorello","year":"2024","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jmir.2026.102569_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijrobp.2013.09.053","article-title":"Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer","volume":"88","author":"Verma","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jmir.2026.102569_bib0016","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3332\/ecancer.2019.957","article-title":"Early toxicity and treatment outcomes of extended field-intensity modulated radiotherapy for cervical cancer patients with para-aortic nodal metastasis","volume":"13","author":"Gupta","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.jmir.2026.102569_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20250143","article-title":"PSMA PET-directed radiotherapy for prostate cancer: from precision planning to future innovations","volume":"7","author":"Huang","year":"2026","journal-title":"VIEW"},{"issue":"1","key":"10.1016\/j.jmir.2026.102569_bib0018","doi-asserted-by":"crossref","first-page":"30","DOI":"10.37549\/ARO-D-23-00029","article-title":"Planning target volume margin assessment of retroperitoneal tumors using robotic SBRT with spine tracking","volume":"13","author":"McKenzie","year":"2024","journal-title":"Appl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.jmir.2026.102569_bib0019","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/1754-9485.13806","article-title":"Radiotherapy for node-positive prostate cancer in the PSMA-PET era: the need for prospective clinical trials","volume":"69","author":"Ong","year":"2025","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"1","key":"10.1016\/j.jmir.2026.102569_bib0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/biomedinformatics4010011","article-title":"Small bowel dose constraints in radiation therapy\u2014where omics-driven biomarkers and bioinformatics can take us in the future","volume":"4","author":"Yariv","year":"2024","journal-title":"BioMedInformatics"}],"container-title":["Journal of Medical Imaging and Radiation Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939865426003838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939865426003838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:34:46Z","timestamp":1788514486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939865426003838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1939865426003838"],"URL":"https:\/\/doi.org\/10.1016\/j.jmir.2026.102569","relation":{},"ISSN":["1939-8654"],"issn-type":[{"value":"1939-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing the therapeutic ratio of PSMA-PET-guided para-aortic radiotherapy for prostate cancer: A systematic review and structured quantitative synthesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Imaging and Radiation Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmir.2026.102569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of Canadian Association of Medical Radiation Technologists.","name":"copyright","label":"Copyright"}],"article-number":"102569"}}